- $1.39bn
- $1.35bn
- $874.59m
- 92
- 50
- 63
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 651 | 667 | 773 | 828 | 875 |
Cost of Revenue | |||||
Gross Profit | 372 | 407 | 496 | 514 | 522 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 630 | 581 | 665 | 734 | 806 |
Operating Profit | 20.2 | 85.3 | 108 | 93.6 | 68.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 24.9 | 89.5 | 105 | 91 | 122 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20.1 | 71.8 | 91.9 | 76.1 | 110 |
Net Income Before Extraordinary Items | |||||
Net Income | 20.1 | 71.8 | 91.9 | 76.1 | 110 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.1 | 71.8 | 91.9 | 76.1 | 110 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.565 | 1.97 | 2.46 | 2.51 | 3.04 |
Dividends per Share |